论文部分内容阅读
雌激素及孕激素受体(ER,PR)对宫内膜癌及卵巢癌内分泌治疗选择及其预后评价逐渐引起重视。ER和PR与发病率较低的输卵管恶性肿瘤之间关系,目前报道极少。本文初步测定了5例人输卵管癌的ER和
Estrogen and progesterone receptors (ER, PR) endometrial cancer and ovarian cancer endocrine therapy options and prognosis gradually attracted attention. The relationship between ER and PR and the lower incidence of tubal malignant tumor, rarely reported. This article preliminary determination of 5 cases of human fallopian tube cancer ER and